Enanta Pharmaceuticals | Ativos



Assets Alterar Data
AbbVie USD 135.16B 8.26B 2024-12
Amgen USD 89.37B 2.47B 2025-03
Arrowhead Research USD 1.57B 559.8M 2025-03
AstraZeneca USD 106.25B 2.22B 2025-03
Biogen USD 28.03B 16.2M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Halozyme Therapeutics USD 2.2B 133.06M 2025-03
Incyte USD 5.75B 305.04M 2025-03
Insmed USD 1.8B 222.5M 2025-03
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
J&J USD 193.67B 13.57B 2025-03
Ligand Pharmaceuticals USD 905.44M 36.34M 2025-03
Merck USD 115.12B 1.98B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
PTC Therapeutics USD 2.66B 950.36M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Enanta Pharmaceuticals Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.